• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary Care.新型阿片类药物安全诊所倡议:在初级保健中提供符合指南的慢性阿片类药物治疗
Mayo Clin Proc Innov Qual Outcomes. 2018 Nov 2;2(4):309-316. doi: 10.1016/j.mayocpiqo.2018.09.005. eCollection 2018 Dec.
2
Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain.《2016 年美国疾病预防控制中心发布慢性疼痛阿片类药物处方指南后初始阿片类药物处方实践的变化》。
JAMA Netw Open. 2021 Jul 1;4(7):e2116860. doi: 10.1001/jamanetworkopen.2021.16860.
3
Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial.遵循长期阿片类药物治疗指南以减少初级保健中阿片类药物滥用情况的改善:一项整群随机临床试验。
JAMA Intern Med. 2017 Sep 1;177(9):1265-1272. doi: 10.1001/jamainternmed.2017.2468.
4
Association of the 2016 US Centers for Disease Control and Prevention Opioid Prescribing Guideline With Changes in Opioid Dispensing After Surgery.2016 年美国疾病控制与预防中心阿片类药物处方指南与术后阿片类药物配药变化的关联。
JAMA Netw Open. 2021 Jun 1;4(6):e2111826. doi: 10.1001/jamanetworkopen.2021.11826.
5
Team-Based Medicine: Incorporating a Clinical Pharmacist into Pain and Opioid Practice Management.团队式医疗:将临床药师纳入疼痛和阿片类药物的实践管理中。
PM R. 2019 Nov;11(11):1170-1177. doi: 10.1002/pmrj.12127. Epub 2019 Apr 16.
6
Mortality After Discontinuation of Primary Care-Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study.基于初级保健的慢性阿片类药物治疗疼痛后停药的死亡率:一项回顾性队列研究。
J Gen Intern Med. 2019 Dec;34(12):2749-2755. doi: 10.1007/s11606-019-05301-2. Epub 2019 Aug 29.
7
Guideline adherence and reasons for recommending dose reduction in a primary care-based opioid management clinic.在基于初级保健的阿片类药物管理诊所中,遵医嘱情况和推荐减少剂量的原因。
J Opioid Manag. 2021 Nov-Dec;17(6):481-488. doi: 10.5055/jom.2021.0682.
8
Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial.改善人类免疫缺陷病毒感染者慢性阿片类药物治疗的传递:一项集群随机临床试验。
Clin Infect Dis. 2021 Oct 5;73(7):e2052-e2058. doi: 10.1093/cid/ciaa1025.
9
Co-prescription of naloxone as a Universal Precautions model for patients on chronic opioid therapy-Observational study.纳洛酮联合处方作为慢性阿片类药物治疗患者的通用预防模型——观察性研究。
Subst Abus. 2016 Oct-Dec;37(4):591-596. doi: 10.1080/08897077.2016.1179704. Epub 2016 Apr 19.
10
Comparison of the Centers for Disease Control (CDC) recommendations and the risk index for overdose or serious opioid-induced respiratory depression (RIOSORD) tool for guiding naloxone coprescribing.比较疾病控制与预防中心(CDC)的建议和用于指导纳洛酮共同处方的阿片类药物过量或严重呼吸抑制风险指数(RIOSORD)工具。
J Opioid Manag. 2023 Mar-Apr;19(2):111-116. doi: 10.5055/jom.2023.0765.

引用本文的文献

1
Guideline concordant opioid therapy in Veterans receiving VA and community care.退伍军人事务部和社区医疗服务中符合指南的阿片类药物治疗。
BMC Health Serv Res. 2024 Oct 26;24(1):1284. doi: 10.1186/s12913-024-11742-1.
2
Assessing the use of a clinical decision support tool for pain management in primary care.评估一种用于初级保健中疼痛管理的临床决策支持工具的使用情况。
JAMIA Open. 2022 Sep 15;5(3):ooac074. doi: 10.1093/jamiaopen/ooac074. eCollection 2022 Oct.
3
Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial.纳洛酮与阿片类药物联合配药:一项整群随机实用试验。
J Gen Intern Med. 2022 Aug;37(11):2624-2633. doi: 10.1007/s11606-021-07356-6. Epub 2022 Feb 7.
4
Guideline adherence and reasons for recommending dose reduction in a primary care-based opioid management clinic.在基于初级保健的阿片类药物管理诊所中,遵医嘱情况和推荐减少剂量的原因。
J Opioid Manag. 2021 Nov-Dec;17(6):481-488. doi: 10.5055/jom.2021.0682.
5
Growing Up Fast!成长迅速!
Mayo Clin Proc Innov Qual Outcomes. 2019 Nov 22;3(4):381-383. doi: 10.1016/j.mayocpiqo.2019.10.009. eCollection 2019 Dec.

本文引用的文献

1
Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.临床环境中对纳洛酮处方的态度:一项针对因慢性非癌性疼痛而开具高剂量阿片类药物的患者的定性研究。
J Gen Intern Med. 2017 Mar;32(3):277-283. doi: 10.1007/s11606-016-3895-8. Epub 2016 Oct 31.
2
Primary Care Patient Experience with Naloxone Prescription.初级保健患者使用纳洛酮处方的体验。
Ann Fam Med. 2016 Sep;14(5):431-6. doi: 10.1370/afm.1972.
3
Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain.纳洛酮联合处方用于接受长期阿片类药物治疗疼痛的初级保健患者的非随机干预研究
Ann Intern Med. 2016 Aug 16;165(4):245-52. doi: 10.7326/M15-2771. Epub 2016 Jun 28.
4
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49. doi: 10.15585/mmwr.rr6501e1.
5
Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.药物和阿片类药物过量死亡人数增加 - 美国,2000-2014 年。
MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378-82. doi: 10.15585/mmwr.mm6450a3.
6
Legal changes to increase access to naloxone for opioid overdose reversal in the United States.美国为增加纳洛酮获取途径以逆转阿片类药物过量而进行的法律变革。
Drug Alcohol Depend. 2015 Dec 1;157:112-20. doi: 10.1016/j.drugalcdep.2015.10.013. Epub 2015 Oct 22.
7
The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy.阿片类药物风险降低措施对接受慢性阿片类药物治疗患者的高剂量阿片类药物处方的影响。
J Pain. 2016 Jan;17(1):101-10. doi: 10.1016/j.jpain.2015.10.002. Epub 2015 Oct 22.
8
Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.基层医疗中为开具阿片类药物的患者提供过量用药教育和纳洛酮:一项关于基层医疗工作人员的定性研究
J Gen Intern Med. 2015 Dec;30(12):1837-44. doi: 10.1007/s11606-015-3394-3.
9
The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.长期阿片类药物治疗慢性疼痛的效果和风险:美国国立卫生研究院预防途径研讨会的系统评价。
Ann Intern Med. 2015 Feb 17;162(4):276-86. doi: 10.7326/M14-2559.
10
Racial disparities in the monitoring of patients on chronic opioid therapy.慢性阿片类药物治疗患者监测中的种族差异。
Pain. 2013 Jan;154(1):46-52. doi: 10.1016/j.pain.2012.07.034.

新型阿片类药物安全诊所倡议:在初级保健中提供符合指南的慢性阿片类药物治疗

Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary Care.

作者信息

Binswanger Ingrid A, Joseph Nicole, Hanratty Rebecca, Gardner Edward M, Durfee Josh, Narwaney Komal J, Breslin Kristin, Mueller Shane R, Glanz Jason M

机构信息

Institute for Health Research, Kaiser Permanente Colorado, Denver, CO.

Colorado Permanente Medical Group, Denver, CO.

出版信息

Mayo Clin Proc Innov Qual Outcomes. 2018 Nov 2;2(4):309-316. doi: 10.1016/j.mayocpiqo.2018.09.005. eCollection 2018 Dec.

DOI:10.1016/j.mayocpiqo.2018.09.005
PMID:30560232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6260499/
Abstract

OBJECTIVE

To develop and evaluate a novel Opioid Safety Clinic (OSC) initiative to enhance adherence to guidelines on the assessment and monitoring of patients prescribed chronic opioid therapy (COT).

PATIENTS AND METHODS

The OSC was developed at an urban Federally Qualified Health Center to provide guideline-concordant care for COT, standardize workflows, and efficiently use clinic staff. We evaluated the OSC using a matched cohort study. Five hundred thirty-nine patients participated in the clinic between July 1, 2014, and March 31, 2016. Of these, 472 clinic participants were matched to 472 nonparticipants by sex and age on the date of the OSC visit. The OSC was evaluated by its completion rates of standardized pain assessments, urine toxicology, and naloxone dispensings. We conducted logistic regression comparing OSC participants to OSC nonparticipants.

RESULTS

A total of 539 patients attended an OSC visit, representing approximately 53% of patients in the chronic opioid registry. The OSC participants were more likely than nonparticipants to have completed a pain assessment (adjusted odds ratio [aOR], 169.8; 95% CI, 98.3-293.5), completed a urine toxicology (aOR, 46.1; 95% CI, 30.4-69.9), or had naloxone dispensed (aOR, 2.8; 95% CI, 1.9-4.3) over 12 months of follow-up.

CONCLUSION

The OSC model improved adherence to guideline-concordant COT in primary care. Future research is needed to assess the impact of these interventions on pain, quality of life, and adverse events from opioid analgesics.

摘要

目的

制定并评估一项新型阿片类药物安全诊所(OSC)倡议,以提高对慢性阿片类药物治疗(COT)患者评估和监测指南的依从性。

患者与方法

OSC在一家城市联邦合格健康中心设立,为COT提供符合指南的护理,规范工作流程,并有效利用诊所工作人员。我们采用匹配队列研究对OSC进行评估。2014年7月1日至2016年3月31日期间,539名患者参与了该诊所。其中,472名诊所参与者在OSC就诊日期按性别和年龄与472名未参与者进行匹配。通过标准化疼痛评估、尿液毒理学和纳洛酮配给的完成率对OSC进行评估。我们进行了逻辑回归,比较OSC参与者和非参与者。

结果

共有539名患者参加了OSC就诊,约占慢性阿片类药物登记患者的53%。在12个月的随访中,OSC参与者比非参与者更有可能完成疼痛评估(调整优势比[aOR],169.8;95%可信区间[CI],98.3 - 293.5)、完成尿液毒理学检查(aOR,46.1;95% CI,30.4 - 69.9)或获得纳洛酮配给(aOR,2.8;95% CI,1.9 - 4.3)。

结论

OSC模式提高了初级保健中对符合指南的COT的依从性。需要进一步研究来评估这些干预措施对疼痛、生活质量和阿片类镇痛药不良事件的影响。